Performance of Large Language Models in Answering Osteoporosis-Related Frequently Asked Questions: A Systematic
Xuhui Wu1, Jing Li1, Shuying Liu1
1Health Management Center, National Clinical Research Center for Endocrine and Metabolic Diseases, Hunan Provincial Clinical Medicine Research Center for Intelligent Management of Chronic Disease, Hunan Provincial Key Laboratory of Metabolic Bone Diseases, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
None:
To systematically evaluate and compare the performance of large language models (LLMs) in answering osteoporosis-related frequently asked questions (FAQs) derived from international osteoporosis-related associations. A standardized question bank was constructed based on FAQs summarized from three international osteoporosis-related associations. Six LLMs were prompted to generate responses to all questions under uniform conditions. Two osteoporosis experts independently and blindly evaluated all responses using 5-point Likert scales for accuracy and comprehensiveness. Inter-rater reliability was assessed using Cohen's κ coefficient. Nonparametric statistical analyses, including Kruskal-Wallis tests with Dunn's post hoc comparisons and Wilcoxon signed-rank tests, were performed to compare models' performance. A total of 528 responses were generated from 88 association-based questions. Inter-rater agreement was good for both accuracy and comprehensiveness (κ = 0.668 and 0.702, respectively). Significant differences were observed among models, with Claude Sonnet 4.5 demonstrating the highest overall performance on association-based FAQs. Although most models showed solid medical knowledge and basic reasoning ability, substantial variability was observed across question types and prompt formulations. Current LLMs demonstrate promising potential as auxiliary tools for osteoporosis-related health management. However, it is necessary to optimize the strategies for integrating medical knowledge and designing prompts, so as to better improve the accessibility of its clinical application.
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Remodeling
